WP
MANE

Woodline Partners’s Veradermics Inc MANE Stock Holding History

Woodline Partners’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.7M Buy
501,590
+944
+0.2% +$88.4K 0.19% 136
2026
Q1 		$31.6M Buy
+500,646
New +$25.3M 0.12% 234

Other funds holding MANE

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Woodline Partners's MANE Position: Q2 2026 in Review

Woodline Partners increased its Veradermics Inc (MANE) stake by 0.19% in Q2 2026, buying an estimated $88.4K and bringing the position to 501,590 shares worth $61.7M. The position accounts for 0.19% of the portfolio, ranked #136.

Woodline Partners first reported a position in MANE in Q1 2026 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • Woodline Partners held 501,590 shares of Veradermics Inc worth $61.7M as of Q2 2026.
  • Woodline Partners bought 944 Veradermics Inc shares in Q2 2026, an estimated $88.4K.
  • Veradermics Inc made up 0.19% of Woodline Partners's portfolio in Q2 2026, its #136 holding.
  • Woodline Partners first reported a position in Veradermics Inc in Q1 2026 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.